Standard course oseltamivir 75mg two times daily for five days was associated with an 82% reduction of odds of in-patient death (OR 0.18 (0.07,0.51)) compared to no oseltamivir treatment (OR 1.0 Reference) in a final multivariable logistic regression model of a retrospective cohort of PCR confirmed influenza B and influenza A (H3N2) infected patients admitted to a large UK teaching hospital in influenza seasons 2016-17 and 2017-18. No difference of protective odds for standard course oseltamivir was observed between influenza B and influenza A (H3N2) nor between influenza seasons. These observations strongly support clinical guidelines for molecular testing for respiratory viruses on admission to hospital and prompt treatment of confirmed seasonal influenza B and A with oseltamivir 75mg twice daily for five days.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Infection
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study.J Infect. 2020; 81: 966-972
- Weekly Influenza and COVID-19 Surveillance graphs. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1128595/Weekly_COVID-19_and_Influenza_Surveillance_Graphs__w2_report.pdf to.week. 2023; 1
United Kingdom Health Security Agency. Guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1058443/ukhsa-guidance-antivirals-influenza-11v4.pdf2021.
- Debate regarding oseltamivir use for seasonal and pandemic influenza.Emerg Infect Dis. 2016; 22: 949-955
- Influenza-associated mortality in hospital care: a retrospective cohort study of risk factors and impact of oseltamivir in an English teaching hospital, 2016 to 2017.Euro Surveill. 2019; 24
Published online: January 13, 2023
Accepted: January 4, 2023
© 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved.